Mount Yale Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,252	Closed	-$641K	–	566
2024 Q3	$641K	Sell	3,252 -151	-4%	-$31.4K	0.06%	289
2024 Q2	$703K	Sell	3,403 -103	-3%	-$23.3K	0.06%	275
2024 Q1	$950K	Buy	3,506 +5	+0.1%	+$1.19K	0.07%	231
2023 Q4	$828K	Sell	3,501 -194	-5%	-$38.2K	0.08%	231
2023 Q3	$724K	Buy	3,695 +13	+0.4%	+$2.67K	0.08%	245
2023 Q2	$774K	Buy	3,682 +182	+5%	+$36.2K	0.08%	241
2023 Q1	$706K	Buy	3,500 +294	+9%	+$66.6K	0.08%	247
2022 Q4	$699K	Buy	3,206 +62	+2%	+$13.5K	0.08%	250
2022 Q3	$619K	Sell	3,144 -24	-0.8%	-$5.18K	0.08%	242
2022 Q2	$678K	Sell	3,168 -36	-1%	-$8.8K	0.09%	239
2022 Q1	$910K	Buy	3,204 +83	+3%	+$25.6K	0.1%	209
2021 Q4	$1.18M	Sell	3,121 -9	-0.3%	-$3.5K	0.12%	182
2021 Q3	$1.29M	Sell	3,130 -196	-6%	-$81.4K	0.15%	154
2021 Q2	$1.23M	Sell	3,326 -210	-6%	-$70.1K	0.15%	145
2021 Q1	$1.02M	Sell	3,536 -691	-16%	-$192K	0.13%	159
2020 Q4	$1.06M	Buy	4,227 +84	+2%	+$20K	0.15%	158
2020 Q3	$938K	Buy	4,143 +36	+0.9%	+$7.47K	0.15%	156
2020 Q2	$716K	Buy	4,107 +401	+11%	+$64K	0.13%	169
2020 Q1	$468K	Buy	3,706 +422	+13%	+$63.3K	0.11%	181
2019 Q4	$508K	Sell	3,284 -76	-2%	-$10.5K	0.09%	197
2019 Q3	$454K	Sell	3,360 -77	-2%	-$10.3K	0.08%	208
2019 Q2	$454K	Sell	3,437 -13	-0.4%	-$1.76K	0.08%	201
2019 Q1	$501K	Sell	3,450 -28	-0.8%	-$3.68K	0.09%	175
2018 Q4	$438K	Sell	3,478 -175	-5%	-$21.9K	0.09%	203
2018 Q3	$498K	Sell	3,653 -50	-1%	-$6.17K	0.09%	173
2018 Q2	$416K	Sell	3,703 -513	-12%	-$55.5K	0.08%	205
2018 Q1	$450K	Buy	+4,216	New	+$454K	0.1%	191